Kamlanoflast In Amyotrophic Lateral Sclerosis

Clinical trial NCT07396818 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07396818
Sponsor: Inflammasome Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ALS (Amyotrophic Lateral Sclerosis)ALS Neuro-Degenerative Disease Neuro-Degenerative Diseases Motor Neuron Disease (MND)

Start date: 2026-02-01
Primary completion: 2027-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.